Cargando…
Therapies to Slow, Stop, or Reverse Parkinson’s Disease
Our understanding of PD pathophysiology is vastly improved compared to the situation 20 years ago. We have identified the major genetic risks for PD, we now have far more representative animal models of the disease, and we can be inspired by the early successes of others using Antisense Oligonucleot...
Autores principales: | Foltynie, Tom, Langston, J. William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311371/ https://www.ncbi.nlm.nih.gov/pubmed/30584162 http://dx.doi.org/10.3233/JPD-181481 |
Ejemplares similares
-
Slowed Movement Stopping in Parkinson’s Disease and Focal Dystonia is Improved by Standard Treatment
por: Choudhury, Supriyo, et al.
Publicado: (2019) -
Technologies Assessing Limb Bradykinesia in Parkinson’s Disease
por: Hasan, Hasan, et al.
Publicado: (2017) -
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
por: Vijiaratnam, Nirosen, et al.
Publicado: (2023) -
Parkinson’s disease dementia: a neural networks perspective
por: Gratwicke, James, et al.
Publicado: (2015) -
Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: The Effect of Varying Stimulation Parameters
por: Dayal, Viswas, et al.
Publicado: (2017)